Meeting Coverage

Thought leaders including Christoph Licht, MD, will discuss how immunologic principles can help clarify diagnosis and treatment in rheumatology practice.

Experts will discuss the latest work to overcome the challenge of having no standard way of knowing who to screen for arthritis-associated interstitial lung disease. Among them, Scott Matson, MD, will share data from molecular phenotyping of RA-ILD.

Steroids have been a mainstay in the treatment of rheumatic diseases for decades, but there are proven toxicities associated with their long-term use. John Stone, MD, MPH, and other panelists will discuss the path to a steroid-free future for patients with rheumatic disease.

Adaobi Ugochukwu, MD, a first-year pediatric resident who was diagnosed with lupus as a child, will share her perspective on living with the disease as part of a larger discussion about challenges to access to care for pediatric rheumatology patients of diverse backgrounds.

Nicola Orlov, MD, MPH, will introduce the audience to feedback scripts, which are essentially a framework that people can use when giving feedback about challenging behaviors.

The safety of patients is of the utmost concern as artificial intelligence rapidly advances into nearly every aspect of healthcare, but there are legal and ethical measures to consider as well, explained Keymanthri Moodley, PhD, MBChB.

Inequities in healthcare are pervasive, but individual rheumatologists can actively participate in efforts to improve outcomes by changing the ways in which they interact with patients. Dubois Lecturer Candace H. Feldman, MD, MPH, ScD, will explain how.

Raphaela Goldbach-Mansky, MD, MHS, will illustrate how pediatric discoveries have helped to link innate immune pathway dysregulation to systemic inflammation and progressive organ damage.

Nunzio Bottini, MD, PhD, will outline the established role of synovial fibroblasts, as well as recent discoveries, making the case that targeting them would solve unmet needs in rheumatoid arthritis.